Picard Medical, Inc. (PMI) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 7.45M USD | Liabilities, Current |
| Cash and equivalents | 38.00K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 5.97M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $7.45M | $38.00K | (m) | (m) | $5.97M | (m) |
| 2026-03-31 | (m) | $12.66M | $121.00K | (m) | (m) | $7.45M | (m) |
| 2025-12-31 | (m) | $18.70M | $7.45M | (m) | (m) | $7.30M | (m) |
| 2025-09-30 | (m) | $5.37M | $2.81M | (m) | (m) | $6.55M | (m) |
| 2025-06-30 | (m) | $45.64M | $410.00K | (m) | $1.30M | $7.00M | (m) |
| 2024-12-31 | (m) | $35.33M | $96.00K | (m) | $513.00K | $8.12M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |